BCL7A Antikörper
Kurzübersicht für BCL7A Antikörper (ABIN7938058)
Target
Alle BCL7A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Bcl7A antibody (pAb)
-
Aufreinigung
- Affinity Purified
-
Immunogen
- This antibody was raised against a peptide within human BCL7A.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500 dilution IP: 5 µL per IP
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Purified IgG in 70 mM Tris, 105 mM NaCl, 0.07 mM EDTA, 31 mM glycine, 0.035 % sodium azide, 30 % glycerol, and 0.5 mg/mL BSA.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions,Keep all reagents on ice when not in storage
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.
-
Haltbarkeit
- 24 months
-
-
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
Andere Bezeichnung
- Bcl7A
-
Hintergrund
-
Background_Plain: Bcl7A (B-cell CLL/lymphoma 7 protein family member A) is a gene which was identified in translocation in Burkitt Lymphoma cells, and has been associated with chromosomal aberrations leading to B-cell non-Hodgkin lymphoma, and is expressed in the majority of precursor and mature B cell lymphomas.The three known BCL7 proteins (BCL7A, BCL7B, and BCL7C) share sequence homology and may play a role in chromatin remodeling.
Aliases: B-cell CLL/lymphoma 7 protein family member A, BCL Tumor Suppressor 7A, BAF Chromatin Remodeling Complex Subunit BCL7A, BAF Complex Component,
-
Molekulargewicht
- 45 kDa
-
NCBI Accession
- NP_001019979
Target
-